Rubeta N Matin
Overview
Explore the profile of Rubeta N Matin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
881
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jones O, Calanzani N, Scott S, Matin R, Emery J, Walter F
JMIR Cancer
. 2025 Jan;
11:e60653.
PMID: 39874580
Background: Skin cancers, including melanoma and keratinocyte cancers, are among the most common cancers worldwide, and their incidence is rising in most populations. Earlier detection of skin cancer leads to...
2.
Wang X, Borsky K, Proctor D, Goodall R, Marshall D, Dobell W, et al.
J Eur Acad Dermatol Venereol
. 2025 Jan;
PMID: 39780527
Background: Cutaneous melanoma (CM) is the leading cause of skin cancer mortality with associated high healthcare costs. Up-to-date reporting of epidemiological trends for CM is required to project future trends,...
3.
Alderman J, Palmer J, Laws E, McCradden M, Ordish J, Ghassemi M, et al.
Lancet Digit Health
. 2024 Dec;
7(1):e64-e88.
PMID: 39701919
Without careful dissection of the ways in which biases can be encoded into artificial intelligence (AI) health technologies, there is a risk of perpetuating existing health inequalities at scale. One...
4.
Jones O, Matin R, Walter F
Lancet Digit Health
. 2024 Dec;
7(1):e8-e10.
PMID: 39665944
No abstract available.
5.
Shah S, Arecco D, Draper H, Tiribelli S, Harriss E, Matin R
Br J Dermatol
. 2024 Nov;
192(3):520-529.
PMID: 39501748
Background: Skin cancer is the most common cancer worldwide. Early diagnosis is crucial to improving patient survival and morbidity. Artificial intelligence (AI)-assisted smartphone applications (apps) for skin cancer potentially offer...
6.
Alderman J, Charalambides M, Sachdeva G, Laws E, Palmer J, Lee E, et al.
Lancet Digit Health
. 2024 Oct;
6(11):e827-e847.
PMID: 39455195
During the COVID-19 pandemic, artificial intelligence (AI) models were created to address health-care resource constraints. Previous research shows that health-care datasets often have limitations, leading to biased AI technologies. This...
7.
Lai C, Fuggle N, Matin R, Tanaka R, Banerji C, Rajan N
Br J Dermatol
. 2024 Oct;
192(1):118-124.
PMID: 39395182
No abstract available.
8.
Kounidas G, Cleer I, Harriss E, Harrison R, Matin R
Clin Exp Dermatol
. 2024 Oct;
50(2):387-394.
PMID: 39373121
Background: Usability is an important method for evaluating mobile health apps from a user perspective. Yet many publicly available apps lack adequate attention to their design, development and evaluation. Objectives:...
9.
Wallace W, Chan C, Chidambaram S, Hanna L, Acharya A, Daniels E, et al.
PLOS Digit Health
. 2024 Aug;
3(8):e0000558.
PMID: 39102377
Online symptom checkers are increasingly popular health technologies that enable patients to input their symptoms to produce diagnoses and triage advice. However, there is concern regarding the performance and safety...
10.
Zaki F, Shephard M, Danby R, Pawson R, Peniket A, Sheppard K, et al.
Clin Exp Dermatol
. 2024 May;
49(11):1413-1419.
PMID: 38738498
We report the cases of 10 patients with oral squamous cell carcinoma (SCC) post-haematopoietic stem cell transplant (HSCT). Median latency from HSCT to oral SCC diagnosis was 10 years (range:...